Cronos Group Inc.
TSX:CRON.TODrug Manufacturers - Specialty & Generic
-$0.01 today
- Market cap
- $1.67B
- Beta
- 1.25
- P/E (TTM)
- -488.1
- EPS (TTM)
- -$0.01
Volume 0.15M
Average 0.19M
CRON.TO Net Income
Bottom-line profit, the starting point for calculating cash from operations.
Cronos Group Inc.TSX: CRON.TO
Net Income · Q1 FY2026 · quarter ended Mar 2026
Net income growth accelerates
Q1 FY2026 net income of $13.53M rose 75.1% year over year, ahead of the -97.0% change in trailing-twelve-month net income. Over 3 fiscal years it compounded at -61.5% a year.
Context
- Net income amounted to 6.4% of revenue in FY2025, down 27.6 pp from a year earlier.
- Net income increased in 2 of the last 3 fiscal years.
What to watch
Whether net income reaches the consensus estimate from 4 analysts of $73.09M (+860.4%) for the fiscal year ending Dec 2026, a step up from the -124.0% reported in FY2025.
Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $13.53M+833.6% QoQ
- Last fiscal yearDec 2025
- -$9.61M-124.0% YoY
- LTMMar 2026
- $1.52M-97.0% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +75.1% | +109.6% | +34.5 pp |
| 1 year | -124.0% | +860.4% | +984.4 pp |
| 3-year CAGR | -61.5% | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
USD · from the cash flow
- Latest · FY2025
- (9.61M) USD
- Year-over-year change
- -124.0%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (9.61M) | -124.0% |
| FY2024 | 2024-12-31 | 40.02M | +153.7% |
| FY2023 | 2023-12-31 | (74.55M) | +55.8% |
| FY2022 | 2022-12-31 | (168.73M) | +57.5% |
| FY2021 | 2021-12-31 | (397.2M) | — |
Net Income vs competitors
How CRON.TO compares with its peers on the latest reported figures
- Peers report in different currencies, so net income is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -97.0% is the lowest of 6, against a peer median of +41.3%.
- Net income amounts to 1.0% of revenue for CRON.TO, versus a peer median of 4.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Feb 2026 | $1.34B USD | +41.3% | +71.3% | 155.6% | |
| LTM Jun 2026 | CA$121.28M CAD | +45.8% | +11.6% | 6.1% | |
| LTM Sep 2026 | CA$52.22M CAD | +32.5% | +61.0% | 4.7% | |
| LTM Mar 2026 | CA$38.73M CAD | +202.9% | -37.9% | 2.6% | |
| LTM Mar 2026 | CA$5.61M CAD | -49.3% | -43.6% | 1.1% | |
| LTM Mar 2026 | $1.52M USD | -97.0% | -61.5% | 1.0% | |
| Peer median (excluding CRON.TO) | — | +41.3% | +11.6% | 4.7% | |
Competitors are the stored peer set for CRON.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (397.2M) | (168.73M) | (74.55M) | 40.02M | (9.61M) |
| Depreciation & Amortization | 15.4M | 13.12M | 8.11M | 9.34M | 14.48M |
| Deferred Income Tax | 222.22M | 0 | 43.32M | 0 | 0 |
| Stock-Based Compensation | 10.15M | 15.12M | 8.77M | 8.7M | 0 |
| Change in Working Capital | (2.01M) | 20.66M | (26.47M) | (311K) | (35.02M) |
| Accounts Receivables | (13.16M) | (2.71M) | 9.21M | (2.51M) | (26.2M) |
| Inventory | 11.57M | (7.22M) | 7.4M | 7.42M | (10.58M) |
| Accounts Payables | (2.37M) | (863K) | (773K) | (7.45M) | 1.13M |
| Other Working Capital | 1.97M | 31.45M | (42.3M) | 2.24M | 636.96K |
| Other Non-Cash Items | (2.18M) | 30.89M | (2.01M) | (38.9M) | 56.47M |
| Operating Cash Flow | (153.62M) | (88.95M) | (42.84M) | 18.84M | 26.32M |
| Capital Expenditures | (12.26M) | (5.03M) | (3.42M) | (13.15M) | (26.17M) |
| Acquisitions (Net) | (1.12M) | 0 | 724K | 5.99M | 2.9M |
| Purchases of Investments | (230M) | (271.38M) | (608.25M) | 0 | (59.44M) |
| Sales of Investments | 215.3M | 268.87M | 532.84M | 185.82M | 5.15M |
| Other Investing Activities | (819K) | 5.7M | 18.61M | (4.25M) | 0 |
| Investing Cash Flow | (28.9M) | (1.84M) | (59.5M) | 175.15M | (77.9M) |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued | 15.73K | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | 0 | (2.85M) | (1.03M) | 0 | (9.91M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (13.46M) | (42.36K) | (2.47K) | (1.23M) | (10.34M) |
| Financing Cash Flow | (13.44M) | (2.9M) | (1.03M) | (1.23M) | (20.25M) |
| Effect of Forex Changes | 4.91M | (28.64M) | 8.01M | (3.25M) | (37.24M) |
| Net Change in Cash | (191.05M) | (122.33M) | (95.35M) | 189.51M | (109.07M) |
| Free Cash Flow | (165.88M) | (93.98M) | (46.26M) | 5.69M | 151.61K |
Cronos Group Inc.
TSX:CRON.TO
Intrinsic Alpha fair value
Locked
Current Price
$4.57
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.